The Association of British Healthcare Industries (ABHI) is taking 120 UK companies to MEDICA 2017, highlighting the desire within the UK to forge deeper, more sustainable trading relationships as the country navigates its departure from the EU.
Held in Düsseldorf in Germany from 13 - 16 November, MEDICA 2017 offers a global platform for companies showcasing their innovative technologies. It also provides a strong platform for delegates to meet with distributors and buyers from around the world to discuss business with existing contacts and to meet with industry peers.
Paul Benton, Managing Director of International at ABHI, said: “The UK is open for business and is keen to forge global healthcare links. With 120 companies exhibiting, we are delighted that the UK Pavilion is at its capacity. The technology on show is a wonderful expression of what the industry has to offer in providing value-based healthcare solutions for patients across the globe.”
As the UK enters a new era for trade and business, the UK government has highlighted medtech, and the broader life sciences sector, as having a critical role in its Industrial Strategy, propelling UK productivity once it leaves the EU. Medtech is now worth over £17 billion to the UK and is part of a £64 billion industry that is UK life sciences. A recent report, The Life Sciences Industrial Strategy, has been welcomed by senior government ministers, and provides the framework for increased funding and support for the sector.
As well as supporting UK export globally, ABHI is also keen to speak to international companies wanting to do business within the UK. Their international membership has been set up to make it more accessible for global companies wishing to partner with their British counterparts.
For more information, email Scarlett.OSullivan@abhi.org.uk or speak to the ABHI team on the UK Pavilion in hall 16G19-5.